Marker Therapeutics, Inc. (MRKR)

1.60 +0.10 (+6.67%) USD  |  NASDAQ  |  Aug 25, 14:29
More

Marker Therapeutics Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 20, 2026 --
August 17, 2026 --
July 09, 2026 --
June 30, 2026 --
May 19, 2026 --
May 18, 2026 --
May 17, 2026 --
March 20, 2026 --
March 19, 2026 --
December 31, 2025 --
December 23, 2025 --
December 08, 2025 --
November 14, 2025 --
October 06, 2025 --
Date Value
September 30, 2025 --
August 26, 2025 --
August 15, 2025 --
June 17, 2025 --
May 20, 2025 --
May 16, 2025 --
May 09, 2025 --
March 31, 2025 --
February 10, 2025 --
December 31, 2024 --
November 15, 2024 --
October 21, 2024 --
September 30, 2024 --
August 16, 2024 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Krystal Biotech, Inc. Upgrade
Tenaya Therapeutics, Inc. Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade
Vericel Corp. Upgrade
SELLAS Life Sciences Group, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade